Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Frankfurt - Delayed Quote EUR

Pharvaris N.V. (9EN.F)

Compare
13.50
-0.80
(-5.59%)
At close: March 5 at 9:55:01 PM GMT+1
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
127,777.10
96,913.62
86,714.61
54,138.63
25,006.59
Operating Income
-127,777.10
-96,913.62
-86,714.61
-54,138.63
-25,006.59
Net Non Operating Interest Income Expense
4,184.97
204.02
-39.25
-282.51
-98.68
Other Income Expense
-7,282.58
-3,116.66
11,100.39
11,760.47
-963.69
Pretax Income
-130,874.71
-99,826.26
-75,653.47
-42,660.66
-26,068.96
Tax Provision
1,333.53
1,048.81
679.09
70.12
-83.25
Net Income Common Stockholders
-132,208.24
-100,875.07
-76,332.56
-42,730.78
-25,985.70
Diluted NI Available to Com Stockholders
-132,208.24
-100,875.07
-76,332.56
-42,730.78
-25,985.70
Basic EPS
-2.60
-2.63
-2.27
-1.40
-0.85
Diluted EPS
-2.60
-2.63
-2.27
-1.40
-0.85
Basic Average Shares
51,489.51
38,391.65
33,585.98
30,411.90
30,519.28
Diluted Average Shares
51,489.51
38,391.65
33,585.98
30,411.90
30,519.28
Total Expenses
127,777.10
96,913.62
86,714.61
54,138.63
25,006.59
Net Income from Continuing & Discontinued Operation
-132,208.24
-100,875.07
-76,332.56
-42,730.78
-25,985.70
Normalized Income
-126,804.56
-98,562.50
-84,569.05
-51,551.13
-25,024.91
Interest Expense
--
--
16.11
267.51
92.47
Net Interest Income
4,184.97
204.02
-39.25
-282.51
-98.68
EBIT
-127,777.10
-96,913.62
-86,714.61
-54,138.63
-25,976.49
EBITDA
-127,532.47
-96,656.07
-86,561.67
-54,061.26
-25,969.08
Reconciled Depreciation
244.63
257.55
152.94
77.37
7.40
Net Income from Continuing Operation Net Minority Interest
-132,208.24
-100,875.07
-76,332.56
-42,730.78
-25,985.70
Total Unusual Items Excluding Goodwill
-7,282.58
-3,116.66
11,100.39
11,760.47
-963.69
Total Unusual Items
-7,282.58
-3,116.66
11,100.39
11,760.47
-963.69
Normalized EBITDA
-120,249.88
-93,539.41
-97,662.06
-65,821.73
-25,005.40
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,878.91
-804.10
2,863.90
2,940.12
-2.89
12/31/2020 - 2/16/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SLNCF Silence Therapeutics plc
1.4700
0.00%
 
MEB.BE Medincell SA
14.52
+2.11%
 
NRXS NeurAxis, Inc.
2.1400
-1.83%
 
XRTX.V XORTX Therapeutics Inc.
1.4900
-3.87%
 
PBLA Panbela Therapeutics, Inc.
0.3500
-2.78%
 
IVA Inventiva S.A.
2.7600
-1.78%
 
IVA.PA Inventiva S.A.
2.6200
0.00%
 
OABI OmniAb, Inc.
3.4100
+1.79%
 
ANTX AN2 Therapeutics, Inc.
1.2500
+8.70%
 
UPB Upstream Bio, Inc.
8.47
+1.56%